Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
December 18, 2025
IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities
Alessandra Mortellaro, Sara Mastaglio, Marta Muzio
Immunological Reviews
|
December 17, 2013
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
Nicoletta Cieri, Sara Mastaglio, Giacomo Oliveira, et al.
Expert Review of Hematology
|
December 14, 2021
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma
Sara Steffanoni, Teresa Calimeri, Nicoletta Anzalone, et al.
Frontiers in Oncology
|
August 4, 2022
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
Massimo Bernardi, Felicetto Ferrara, Matteo Giovanni Carrabba, et al.
Blood Advances
|
February 17, 2018
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy
Sara Mastaglio, Eric Wong, Travis Perera, et al.
Retina (Philadelphia, Pa.)
|
April 21, 2022
RETINAL MICROVASCULAR CHANGES IN PATIENTS WITH ACUTE LEUKEMIA
Maria V Cicinelli, Sara Mastaglio, Matteo Menean, et al.
Frontiers in Oncology
|
September 15, 2022
Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
Matteo Pederzolli, Fabio Giglio, Maria Vittoria Cicinelli, et al.
Acta Ophthalmologica
|
January 26, 2023
Imaging biomarkers of leukaemic choroidopathy
Matteo Menean, Aurelio Apuzzo, Sara Mastaglio, et al.
Blood
|
May 3, 2011
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
Attilio Bondanza, Lothar Hambach, Zohara Aghai, et al.
Human Gene Therapy
|
March 12, 2015
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition
Angela R Elia, Paola Circosta, Dario Sangiolo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Cellular and Molecular Life Sciences : CMLS
|
December 18, 2025
IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities
Alessandra Mortellaro, Sara Mastaglio, Marta Muzio
Immunological Reviews
|
December 17, 2013
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
Nicoletta Cieri, Sara Mastaglio, Giacomo Oliveira, et al.
Expert Review of Hematology
|
December 14, 2021
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma
Sara Steffanoni, Teresa Calimeri, Nicoletta Anzalone, et al.
Frontiers in Oncology
|
August 4, 2022
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
Massimo Bernardi, Felicetto Ferrara, Matteo Giovanni Carrabba, et al.
Blood Advances
|
February 17, 2018
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy
Sara Mastaglio, Eric Wong, Travis Perera, et al.
Retina (Philadelphia, Pa.)
|
April 21, 2022
RETINAL MICROVASCULAR CHANGES IN PATIENTS WITH ACUTE LEUKEMIA
Maria V Cicinelli, Sara Mastaglio, Matteo Menean, et al.
Frontiers in Oncology
|
September 15, 2022
Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
Matteo Pederzolli, Fabio Giglio, Maria Vittoria Cicinelli, et al.
Acta Ophthalmologica
|
January 26, 2023
Imaging biomarkers of leukaemic choroidopathy
Matteo Menean, Aurelio Apuzzo, Sara Mastaglio, et al.
Blood
|
May 3, 2011
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors
Attilio Bondanza, Lothar Hambach, Zohara Aghai, et al.
Human Gene Therapy
|
March 12, 2015
Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition
Angela R Elia, Paola Circosta, Dario Sangiolo, et al.
Page
of 5